Sorafenib for the treatment of unresectable hepatocellular carcinoma
Junji FuruseDepartment of Internal Medicine, Medical Oncology, School of Medicine, Kyorin UniversityAbstract: Raf kinases and vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) tyrosine kinases are potential molecular targets for obtaining both an...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-11-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/sorafenib-for-the-treatment-of-unresectable-hepatocellular-carcinoma-a2576 |